Leman Damla Kotan1, Gaetan Ternier2, Paolo Giacobini3, A Kemal Topaloglu4,5, Aydilek Dagdeviren Cakir6, Hamdi Cihan Emeksiz7, Ihsan Turan1, Gaspard Delpouve2, Asli Derya Kardelen8, Bahar Ozcabi9, Emregul Isik10, Eda Mengen11, Esra Deniz P Cakir12, Aysegul Yuksel13, Sebahat Yilmaz Agladioglu14, Semine Ozdemir Dilek1, Olcay Evliyaoglu6, Feyza Darendeliler8, Fatih Gurbuz1, Gamze Akkus15, Bilgin Yuksel1. 1. Division of Pediatric Endocrinology, Cukurova University, Faculty of Medicine, Adana, Turkey. 2. Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, Lille, France. 3. Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, Lille, France. paolo.giacobini@inserm.fr. 4. Department of Pediatrics, Division of Pediatric Endocrinology, University of Mississippi Medical Center, Jackson, MS, USA. ktopaloglu@umc.edu. 5. Department of Neurobiology and Anatomical Sciences, University of Mississippi Medical Center, Jackson, MS, USA. ktopaloglu@umc.edu. 6. Division of Pediatric Endocrinology, Istanbul University, Cerrahpasa Faculty of Medicine, Istanbul, Turkey. 7. Division of Pediatric Endocrinology, Istanbul Medeniyet University, Faculty of Medicine, Istanbul, Turkey. 8. Division of Pediatric Endocrinology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey. 9. Division of Pediatric Endocrinology, Health Sciences University, Zeynep Kamil Maternity and Children's Training and Research Hospital, Istanbul, Turkey. 10. Clinic of Pediatric Endocrinology, Afyonkarahisar State Hospital, Afyonkarahisar, Turkey. 11. Clinic of Pediatric Endocrinology, Ankara City Hospital, Children's Hospital, Ankara, Turkey. 12. Division of Pediatric Endocrinology, Health Sciences University, Istanbul Bakırkoy Dr. Sadi Konuk Research and Training Hospital, Istanbul, Turkey. 13. Clinic of Pediatric Endocrinology, Health Sciences University, Derince Training and Research Hospital, Kocaeli, Turkey. 14. Clinic of Pediatric Endocrinology, Memorial Hospital, Istanbul, Turkey. 15. Division of Endocrinology and Metabolism, Cukurova University, Faculty of Medicine, Adana, Turkey.
Abstract
PURPOSE: Idiopathic hypogonadotropic hypogonadism (IHH) is characterized by absent puberty and subsequent infertility due to gonadotropin-releasing hormone (GnRH) deficiency. IHH can be accompanied by normal or compromised olfaction (Kallmann syndrome). Several semaphorins are known potent modulators of GnRH, olfactory, and vomeronasal system development. In this study, we investigated the role of Semaphorin-3F signaling in the etiology of IHH. METHODS: We screened 216 IHH patients by exome sequencing. We transiently transfected HEK293T cells with plasmids encoding wild type (WT) or corresponding variants to investigate the functional consequences. We performed fluorescent IHC to assess SEMA3F and PLXNA3 expression both in the nasal region and at the nasal/forebrain junction during the early human fetal development. RESULTS: We identified ten rare missense variants in SEMA3F and PLXNA3 in 15 patients from 11 independent families. Most of these variants were predicted to be deleterious by functional assays. SEMA3F and PLXNA3 are both expressed along the olfactory nerve and intracranial projection of the vomeronasal nerve/terminal nerve. PLXNA1-A3 are expressed in the early migratory GnRH neurons. CONCLUSION: SEMA3F signaling through PLXNA1-A3 is involved in the guidance of GnRH neurons and of olfactory and vomeronasal nerve fibers in humans. Overall, our findings suggest that Semaphorin-3F signaling insufficiency contributes to the pathogenesis of IHH.
PURPOSE: Idiopathic hypogonadotropic hypogonadism (IHH) is characterized by absent puberty and subsequent infertility due to gonadotropin-releasing hormone (GnRH) deficiency. IHH can be accompanied by normal or compromised olfaction (Kallmann syndrome). Several semaphorins are known potent modulators of GnRH, olfactory, and vomeronasal system development. In this study, we investigated the role of Semaphorin-3F signaling in the etiology of IHH. METHODS: We screened 216 IHH patients by exome sequencing. We transiently transfected HEK293T cells with plasmids encoding wild type (WT) or corresponding variants to investigate the functional consequences. We performed fluorescent IHC to assess SEMA3F and PLXNA3 expression both in the nasal region and at the nasal/forebrain junction during the early human fetal development. RESULTS: We identified ten rare missense variants in SEMA3F and PLXNA3 in 15 patients from 11 independent families. Most of these variants were predicted to be deleterious by functional assays. SEMA3F and PLXNA3 are both expressed along the olfactory nerve and intracranial projection of the vomeronasal nerve/terminal nerve. PLXNA1-A3 are expressed in the early migratory GnRH neurons. CONCLUSION: SEMA3F signaling through PLXNA1-A3 is involved in the guidance of GnRH neurons and of olfactory and vomeronasal nerve fibers in humans. Overall, our findings suggest that Semaphorin-3F signaling insufficiency contributes to the pathogenesis of IHH.
Authors: Natasha T Strande; Erin Rooney Riggs; Adam H Buchanan; Ozge Ceyhan-Birsoy; Marina DiStefano; Selina S Dwight; Jenny Goldstein; Rajarshi Ghosh; Bryce A Seifert; Tam P Sneddon; Matt W Wright; Laura V Milko; J Michael Cherry; Monica A Giovanni; Michael F Murray; Julianne M O'Daniel; Erin M Ramos; Avni B Santani; Alan F Scott; Sharon E Plon; Heidi L Rehm; Christa L Martin; Jonathan S Berg Journal: Am J Hum Genet Date: 2017-05-25 Impact factor: 11.025
Authors: Filippo Casoni; Samuel A Malone; Morgane Belle; Federico Luzzati; Francis Collier; Cecile Allet; Erik Hrabovszky; Sowmyalakshmi Rasika; Vincent Prevot; Alain Chédotal; Paolo Giacobini Journal: Development Date: 2016-11-01 Impact factor: 6.868
Authors: Valerie F Sidhoum; Yee-Ming Chan; Margaret F Lippincott; Ravikumar Balasubramanian; Richard Quinton; Lacey Plummer; Andrew Dwyer; Nelly Pitteloud; Frances J Hayes; Janet E Hall; Kathryn A Martin; Paul A Boepple; Stephanie B Seminara Journal: J Clin Endocrinol Metab Date: 2013-01-01 Impact factor: 5.958
Authors: Andrea Messina; Kristiina Pulli; Sara Santini; James Acierno; Johanna Känsäkoski; Daniele Cassatella; Cheng Xu; Filippo Casoni; Samuel A Malone; Gaetan Ternier; Daniele Conte; Yisrael Sidis; Johanna Tommiska; Kirsi Vaaralahti; Andrew Dwyer; Yoav Gothilf; Giorgio R Merlo; Federico Santoni; Nicolas J Niederländer; Paolo Giacobini; Taneli Raivio; Nelly Pitteloud Journal: Am J Hum Genet Date: 2019-12-26 Impact factor: 11.025